NCT00680602View on ClinicalTrials.gov

Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Obsessive Compulsive Disorder
Interventions
BEHAVIORAL

Group Cognitive Behavior Therapy

Structured protocol described by Cordioli et al., 2003

DRUG

SSRI (fluoxetine, sertraline, paroxetine, citalopram)

Fluoxetine (80mg/day or maximum tolerated dosage) Sertraline (200mg/day or maximum tolerated dosage) Paroxetine (60 mg/day or maximum tolerated dosage) Citalopram (60 mg/day or maximum tolerated dosage)

Trial Locations (1)

05403-010

Institute of Psychiatry, Clinics Hospital, University of São Paulo Medical School, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT00680602 - Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial | Biotech Hunter | Biotech Hunter